Biomea Fusion Crashes 65% After FDA Puts Diabetes Treatment Studies On Hold

Biomea stock crashed Friday after the Food and Drug Administration placed two of the company's diabetes treatment studies on hold, citing concerns of liver toxicity.Please watch the video at Investors ... > react

Open the Full Article Open the Full Article - Posted 3 weeks ago

React to this Article

Your Name or Nickname

Your Email (will not be shown)
2 x 3 = ?

The source opens up when you press the "Open The Full Article" link above. Its content doesn't belong to us, we're not responsible for it. If you don't think this content is appropriate, or if you're the owner of the source and do not wish to have your article displayed here, please just contact us.

Latest Arkansas News Reports